Related Experiment Video
Updated: Oct 22, 2025

Dissection and Culture of Mouse Embryonic Kidney
Published on: May 17, 2017
The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread
Alexandros Pergaris1, Eugene Danas1, Dimitrios Goutas1
1First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Abstract:
Erythropoietin-producing human hepatocellular receptors (EPHs) compose the largest known subfamily of receptor tyrosine kinases (RTKs). They bind and interact with the EPH family receptor interacting proteins (ephrins). EPHs/ephrins are implicated in a variety of physiological processes, as well as in cancer pathogenesis. With neoplastic disease remaining a leading cause of death world-wide, the development of novel biomarkers aiding in the field of diagnosis, prognosis, and disease monitoring is of utmost importance. A multitude of studies have proven the association between the expression of members of the EPH/ephrin system and various clinicopathological parameters, including disease stage, tumor histologic grade, and patients' overall survival. Besides their utilization in timely disease detection and assessment of outcome, EPHs/ephrins could also represent possible novel therapeutic targets. The aim of the current review of the literature was to present the existing data regarding the association between EPH/ephrin system expression and the clinical characteristics of malignant tumors.
More Related Videos
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Mitogens and the Cell Cycle
Intracellular Signaling Affects Focal Adhesions
Some...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
The Tumor Microenvironment
Clinical Applications of Epidermal Stem Cells

